Mayo Clinic researchers have identified a new set of molecular markers in blood plasma. This discovery could lead to the development of improved diagnostic tests for Alzheimer's disease. Alzheimer's disease is the most common ...
Mar 17, 2022
0
3
Alzheimer's disease (AD) eventually leads to severe cognitive decline, but most affected individuals also develop distressing neuropsychiatric symptoms. These earlier effects may be more subtle and are not well understood; ...
Mar 16, 2022
0
30
Genetics play an important role in how our bodies respond to vaccines and booster shots, suggesting that certain protective responses elicited by vaccination could be more effective with personalization, according to a new ...
Feb 23, 2022
0
21
January is National Blood Donor Month, which makes this a good time to become a blood donor.
Jan 20, 2022
0
0
Convalescent plasma therapy was one of the first treatments available in the battle against COVID-19. But since the therapy's emergency use authorization by the Food and Drug Administration in August 2020, its supposed benefits ...
Jan 19, 2022
0
26
The first-ever, in-depth characterization of the body's response to traumatic injury was published today in Cell Reports Medicine by University of Pittsburgh School of Medicine physician-scientists. The results of their multiomics ...
Dec 21, 2021
0
38
COVID treatments using plasma taken from the blood of recovered coronavirus patients should not be given to people with mild or moderate illness, the World Health Organization said Tuesday.
Dec 7, 2021
0
18
When dental implants are inserted, saliva or blood plasma immediately coat them. The implants adsorb a thin layer of proteins from these fluids that help gum tissue attach, but also allow microorganisms—including potentially ...
Sep 7, 2021
0
33
Nearly 20% of patients with multiple myeloma have a form in which they make extreme quantities of one component of the abnormal antibody they are producing, and these so-called "free monoclonal light chains" pile up and damage ...
Aug 31, 2021
0
2
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, ...
Aug 19, 2021
0
343
